1. Lipids
  2. Sphingolipids
  3. Sphingomyelins

Sphingomyelins

Sphingomyelins (26):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-141629
    N-Palmitoyl-D-sphingomyelin 6254-89-3 99.90%
    N-palmitoyl-D-sphingomyelin (sphingomyelin 16:0) is a component of LDL-carrying liposomes. N-palmitoyl-D-sphingomyelin can be used in colorectal cancer research.
    N-Palmitoyl-D-sphingomyelin
  • HY-D1574
    C6 NBD Sphingomyelin 94885-04-8 98.0%
    C6 NBD Sphingomyelin is a fluorescent short-chain analogue of Sphingomyelin (HY-113498). Chlamydia trachomatis acquires C6 NBD Sphingomyelin endogenously synthesizes from C6-NBD-ceramide and transportes to the chlamydial inclusion. C6 NBD Sphingomyelin can incorporate into the plasma membrane.
    C6 NBD Sphingomyelin
  • HY-W923642
    Sphingomyelin (d18:1/12:0) 474923-21-2 99.0%
    Sphingomyelin (d18:1/12:0) is a metabolomic biomarker. Sphingomyelin (d18:1/12:0) exhibits favorable diagnostic properties and may facilitate the early detection and targeted prevention of dyslipidemia-related adverse cardiovascular events.
    Sphingomyelin (d18:1/12:0)
  • HY-165136
    Sphingomyelins, milk 475662-40-9 99.20%
    Sphingomyelins, milk (SMs (buttermilk)) are compounds studied in sphingolipids, which play important roles in various biological processes.
    Sphingomyelins, milk
  • HY-D1584
    C12 NBD Sphingomyelin 254117-01-6 99.0%
    C12 NBD sphingomyelin is an active derivative of Sphingomyelin (HY-113498) that is tagged with fluorescent C12 nitrobenzoxadiazole (C12 NBD). C12 NBD sphingomyelin can be used as a sphingomyelinase substrate for studying the metabolism and transport of sphingomyelins (Ex=470 nm, Em=525 nm).
    C12 NBD Sphingomyelin
  • HY-148388
    N-Stearoylsphingomyelin 58909-84-5 98.60%
    N-Stearoylsphingomyelin (N-Stearoyl-D-sphingomyelin) is a sphingolipid, which can inhibit Phospholipase Cδ1 (PLCδ1).
    N-Stearoylsphingomyelin
  • HY-128388
    N-Palmitoyldihydrosphingomyelin 60322-02-3 99%
    N-Palmitoyldihydrosphingomyelin (16:0 Dihydro SM (d18:0/16:0)) is a dihydrosphingomyelin.
    N-Palmitoyldihydrosphingomyelin
  • HY-N11177
    N-Nervonoyl-D-erythro-sphingosylphosphorylcholine 94359-13-4 99.0%
    N-Nervonoyl-D-erythro-sphingosylphosphorylcholine is a biochemical reagent.
    N-Nervonoyl-D-erythro-sphingosylphosphorylcholine
  • HY-113934
    L-threo Lysosphingomyelin (d18:1) 105615-55-2 98.0%
    L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) is an endogenous bioactive sphingolipid. L-threo Lysosphingomyelin (d18:1) is a potent S1P receptor agonist with EC50s of 19.3, 131.8, and 313.3 nM for hS1P1, hS1P3, and hS1P2, respectively.
    L-threo Lysosphingomyelin (d18:1)
  • HY-N15352
    C20 Sphingomyelin (d18:1/20:1) 222403-67-0
    C20 Sphingomyelin (d18:1/20:1) is a sphingomyelin substance. The level of C20 Sphingomyelin (d18:1/20:1) is associated with amyotrophic lateral sclerosis and primary lateral sclerosis.
    C20 Sphingomyelin (d18:1/20:1)
  • HY-165062
    C18 Sphingomyelin (d18:1/18:0) 54336-69-5 98%
    C18 Sphingomyelin (d18:1/18:0) is a form of sphingomyelin and can be used for study of sphingolipid metabolites.
    C18 Sphingomyelin (d18:1/18:0)
  • HY-131676
    C17 Sphingomyelin (d18:1/17:0) 121999-64-2 99.67%
    C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin.
    C17 Sphingomyelin (d18:1/17:0)
  • HY-177003
    SM (d18:1/15:0) 121999-58-4
    SM (d18:1/15:0) is a sphingomyelinase inhibitor. SM (d18:1/15:0) is promising for research of neurodegenerative diseases (e.g., Alzheimer's) and metabolic syndrome.
    SM (d18:1/15:0)
  • HY-N16304
    14:0 Dihydro SM (d18:0/14:0) 871577-10-5
    14:0 Dihydro SM (d18:0/14:0) is a sphingomyelin.
    14:0 Dihydro SM (d18:0/14:0)
  • HY-145549
    C20 Sphingomyelin (d18:1/20:0) 121999-68-6
    C20 Sphingomyelin (d18:1/20:0) (N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine; SM(d18:1/20:0)) is a naturally occurring sphingolipid. C20 Sphingomyelin (d18:1/20:0) levels are upregulated in the hippocampus of streptozotocin (HY-13753)-induced diabetic rats and in human plasma, positively correlating with insulin resistance in obese humans. C20 Sphingomyelin (d18:1/20:0) is also upregulated in the liver of a mouse model of Niemann-Pick C1 disease, a neurodegenerative cholesterol sphingolipid lysosomal storage disorder.
    C20 Sphingomyelin (d18:1/20:0)
  • HY-N17702
    CerPCho (d18:0/22:0) 221097-58-1
    CerPCho (d18:0/22:0) is a sphingomyelin with a d18:0-type sphingosine long-chain base and a 22:0-type N-acyl fatty acid.
    CerPCho (d18:0/22:0)
  • HY-179759
    28:0 SM (d18:1/28:0) 1425088-71-6
    28:0 SM (d18:1/28:0) is a lycerophospholipid.
    28:0 SM (d18:1/28:0)
  • HY-179855
    N-Lauroyl-D-erythro-sphinganylphosphorylcholine 474923-31-4
    N-Lauroyl-D-erythro-sphinganylphosphorylcholine is a phosphosphingolipid.
    N-Lauroyl-D-erythro-sphinganylphosphorylcholine
  • HY-W923633
    N-Lignoceroyl-D-erythro-sphingosylphosphorylcholine 60037-60-7
    N-Lignoceroyl-D-erythro-sphingosylphosphorylcholine is a phosphosphingolipid.
    N-Lignoceroyl-D-erythro-sphingosylphosphorylcholine
  • HY-146930
    16:1 SM (d18:1/16:1) 222403-66-9
    16:1 SM (d18:1/16:1) is a phosphosphingolipid.
    16:1 SM (d18:1/16:1)